A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD... von Ballova, V., Rüffer, J.-U., Haverkamp, H., Pfistner, B., Müller-Hermelink, H. K., Dühmke, E., Worst, P., Wilhelmy, M., Naumann, R., Hentrich, M., Eich, H. T., Josting, A., Löffler, M., Diehl, V., Engert, A.

Volltext

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from th... von Klimm, B., Eich, H.T., Haverkamp, H., Lohri, A., Koch, P., Boissevain, F., Trenn, G., Worst, P., Dühmke, E., Müller, R.P., Müller-Hermelink, K., Pfistner, B., Diehl, V., Engert, A.

Volltext

International harmonization of trial parameters in malignant lymphoma von Pfistner, B., Diehl, V., Greb, A., Cheson, B.

Volltext

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a ra... von Schmitz, Norbert, Pfistner, Beate, Sextro, Michael, Sieber, Markus, Carella, Angelo M, Haenel, Matthias, Boissevain, Friederike, Zschaber, Reinhart, Müller, Peter, Kirchner, Hartmut, Lohri, Andreas, Decker, Susanne, Koch, Bettina, Hasenclever, Dirk, Goldstone, Anthony H, Diehl, Volker

Volltext

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable... von ENGERT, Andreas, SCHILLER, Petra, WILLICH, Normann, MÜLLER, Rolf-Peter, SCHMIDT, Bernhard F, RENNER, Helmut, MÜLLER-HERMELINK, Hans Konrad, PFISTNER, Beate, WOLF, Jürgen, HASENCLEVER, Dirk, LÖFFLER, Markus, DIEHL, Volker, JOSTING, Andreas, HERRMANN, Richard, KOCH, Peter, SIEBER, Markus, BOISSEVAIN, Friederike, DE WIT, Maike, MEZGER, Jörg, DÜHMKE, Eckhart

Volltext

Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial von Sieber, M., Tesch, H., Pfistner, B., Rueffer, U., Paulus, U., Munker, R., Hermann, R., Doelken, G., Koch, P., Oertel, J., Roller, S., Worst, P., Bischof, H., Glunz, A., Greil, R., von Kalle, K., Schalk, K. P., Hasenclever, D., Brosteanu, O., Duehmke, E., Georgii, A., Engert, A., Loeffler, M., Diehl, V.

Volltext

OP31 10-year results of the HD9 trial of the German Hodgkin Study Group comparing baseline and escalated BEACOPP chemotherapy for advanced Hodgkin lymphoma von Engert, A, Franklin, J, Pfistner, B, Diehl, V

Volltext

Hodgkin's Lymphoma in Elderly Patients: A Comprehensive Retrospective Analysis From the German Hodgkin's Study Group von ENGERT, Andreas, BALLOVA, Veronika, HAVERKAMP, Heinz, PFISTNER, Beate, JOSTING, Andreas, DÜHMKE, Eckhart, MÜLLER-HERMELINK, Konrad, DIEHL, Volker

Volltext

Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with re... von Smardova, L, Engert, A, Haverkamp, H, Raemakers, JM, Baars, JW, Pfistner, B, Diehl, V, Josting, A

Volltext

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgki... von Boudová, Ludmila, Torlakovic, Emina, Delabie, Jan, Reimer, Peter, Pfistner, Beate, Wiedenmann, Sabine, Diehl, Volker, Müller-Hermelink, Hans-Konrad, Rüdiger, Thomas

Volltext

Role of Hematotoxicity and Sex in Patients With Hodgkin's Lymphoma: An Analysis From the German Hodgkin Study Group von KLIMM, Beate, REMEKE, Thorsten, HAVERKAMP, Heinz, BEHRINGER, Karolin, EICH, Hans T, JOSTING, Andreas, PFISTNER, Beate, DIEHL, Volker, ENGERT, Andreas

Volltext

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemothe... von GLOSSMANN, J.-P, JOSTING, A, PFISTNER, B, PAULUS, U, ENGERT, A

Volltext

Ten-year results of a German Hodgkin Study Group randomized trial of standard and increased dose BEACOPP chemotherapy for advanced Hodgkin lymphoma (HD9) von Diehl, V., Franklin, J., Pfistner, B., Engert, A.

Volltext

Current treatment strategies of the German Hodgkin Study Group (GHSG) von Klimm, Beate, Diehl, Volker, Pfistner, Beate, Engert, Andreas

Volltext

Rapidly Alternating COPP/ABV/IMEP Is Not Superior to Conventional Alternating COPP/ABVD in Combination With Extended-Field Radiotherapy in Intermediate-Stage Hodgkin’s Lymphoma: Fi... von Sieber, M.

Volltext

171 von Eich, H.T., Mueller, R.P., Brillant, C., Engert, A., Franklin, J., Hansemann, K., Skripnitchenko, R., Staar, S., Pfistner, B., Diehl, V.

Volltext

A comparison of toxicity and outcome following BEACOPP therapy in adolescents and young adults with Hodgkin’s disease (HD) by pediatric and adult oncology cooperative groups von Sposto, R., Kelly, K. M., Villaluna, D., Gilman, E., Pfistner, B., Diehl, V.

Volltext

171: A Contribution To Solve The Problem of The Need For Consolidative Radiotherapy After Intensive Chemotherapy In Advanced Stage Hodgkin′s Lymphoma - Fourth Interim Analysis of T... von Eich, H.T., Mueller, R.P., Brillant, C., Engert, A., Franklin, J., Hansemann, K., Skripnitchenko, R., Staar, S., Pfistner, B., Diehl, V.

Volltext

Recommendations for revised response criteria for malignant lymphoma von Cheson, B. D., Pfistner, B., Juweid, M. E., Horning, S. J., Coiffier, B., Gascoyne, R. D., Fisher, R. I., Hagenbeek, A., Hoppe, R. T., Diehl, V.

Volltext

Beacopp Chemotherapy for Advanced Hodgkin's Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG) von Diehl, Volker, Brillant, C., Franklin, J., Hermann, R., Greil, R., Engert, A., Pfistner, B.

Volltext